ADPT

Q: What is the price of Adaptive Biotechnologies (ADPT) today?

The price of Adaptive Biotechnologies (ADPT) today is $ 14.81, with return of 98.26% compared to the last year. The price of Adaptive Biotechnologies (ADPT) started the year trading around $ 16.24 and today it is at $ 14.81. Follow the real-time price chart, the historical price of Adaptive Biotechnologies (ADPT) and international markets.

Q: When does Adaptive Biotechnologies (ADPT) pay dividends?

Adaptive Biotechnologies (ADPT) did not distribute dividends in the last year.

Q: Is Adaptive Biotechnologies (ADPT) worth it?

Currently, Adaptive Biotechnologies (ADPT) is priced at $ 14.81, with a P/E of -38.09%, representing a deviation of -1,309% from its historical average P/E. In the last year, the stock showed a variation of 98.26 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 98.26%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Adaptive Biotechnologies (ADPT) stock?

Investing in stocks of Adaptive Biotechnologies (ADPT) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Adaptive Biotechnologies (ADPT) yield today?

The yield of Adaptive Biotechnologies (ADPT) was -7.03% in the last month, 98.26% in the last year and -65.16% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Adaptive Biotechnologies (ADPT) today, the total investment would be $ 1,481.00, based on the current price of $ 14.81.If past performance were to repeat, the return on your investment would be:In 1 year: $ 2,936.23In 5 years: $ 515.98In 10 years: $ 1,481.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Adaptive Biotechnologies Corporation

Price

$ 14.81

return (12m)

98.26%

p/e

-38.09

p/bv

10.07

DIVIDEND YIELD

0.00%

ADPT price

ADPT

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ADPT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.03%

3 months

-6.91%

1 year

98.26%

2 years

442.49%

5 years

-65.16%

10 years

0.00%

Fundamentals ADPT

review the fundamentals of Adaptive Biotechnologies shares

P/E

-38.09

Sector: -4.36 Industry: -13.38

P/S (PSR)

8.18

Sector: 1.79 Industry: 2.90

P/BV

10.07

Sector: 2.09 Industry: 1.79

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-11.60%

Sector: -30.33% Industry: -67.81%

ROE

-26.44%

Sector: -39.83% Industry: -59.34%

ROIC

-18.14%

Sector: -418.66% Industry: -484.72%

NET MARGIN

-21.48%

Sector: -32.52% Industry: -43.03%

GROSS MARGIN

74.24%

Sector: 42.44% Industry: 41.46%

OPERATING MARGIN

-20.62%

Sector: -27.49% Industry: -38.68%

EV/EBITDA

-67.42

Sector: -2.68 Industry: -9.74

EV/EBIT

-47.51

Sector: -3.96 Industry: -11.20

PRICE-TO-ASSETS

4.42

Sector: 1.06 Industry: 1.14

BVPS

1.47

Sector: 3.44 Industry: 1.62

EPS

-0.39

Sector: -1.07 Industry: -1.89

EQUITY-TO-ASSETS RATIO

0.44

Sector: 0.39 Industry: 0.32

LIABILITIES / ASSETS

0.56

Sector: 0.45 Industry: 0.36

CAGR REVENUE 5 YEARS

12.41%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-22.09%

Sector: - Industry: -

Fundamentals ADPT

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.57	35.11	86.53%	0.67%	$ 837.34 B	31.66%
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
SNY	12.82	1.39	10.86%	4.62%	$ 116.90 B	18.68%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
GSK	14.82	5.29	35.71%	2.96%	$ 113.04 B	17.48%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
IDXX	43.01	28.38	65.99%	0.00%	$ 45.56 B	24.62%
RMD	22.02	5.18	23.51%	1.04%	$ 32.72 B	27.53%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ADPT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Adaptive Biotechnologies

Adaptive Biotechnologies Corporation

Average Investor10 user rating

4.0 (3 people)

United States

17 years

Founded: 2009

2019

Time since IPO - 7 years

453

Employees

The Company Adaptive Biotechnologies Corporation (United States), is listed on Nasdaq with a market value of $ 2.27 Billions, having an equity of $ 225.00 Millions.

With a total of 453 employees, the company is listed in the sector of Health and categorized in industry of Life Science Tools and Services.

In the last 12 months the Company had a revenue of $ 276.97 Millions, which generated a loss in the amount of $ -59.49 Millions.

As for its main indicators, the Company has a P/E ratio of -38.09, a P/BV ratio of 10.07 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ADPT.

Market cap

$ 2.27 Billions

Net worth

$ 225.00 Millions

US$ 225,000,000.00

Assets

$ 512.74 Millions

US$ 512,740,000.00

Total Shares Outstanding

153.00 Millions

153,000,000

Average Daily Trading Volume

$ 2.05 Millions

US$ 2,047,908.56

Sector

Health

Industry

Life Science Tools and Services

ADPT

ADPT revenue and profits

Financial Results ADPT

DRAG THE FRAME TO SEE MORE DATA

ADPT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 73.49 20,94% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 270.02 --14,47% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 35.11 --43,31% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 177.83 --28,58% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 471.84 43,24% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 935.58 30,21% (12M)

P/E

40.57

0.67%

ROE

86.53%

P/BV

35.11

NVS - Novartis

$ 154.03 53,71% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34